πŸ‡ΊπŸ‡Έ FDA
Patent

US 10570124

Deoxycytidine kinase binding compounds

granted A61PA61P35/00

Quick answer

US patent 10570124 (Deoxycytidine kinase binding compounds) held by The Regents of the University of California expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61P, A61P35/00